Navigation Links
Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension

t indicate treatment-limiting toxicity. The most common adverse event in both treatment groups was upper abdominal pain, which occurred in less than 2% of patients.

Prexige has a different chemical structure from other COX-2 inhibitors. It is the only one that does not contain a sulphur molecule, which has been associated with sulphur-related skin reactions in some patients. Prexige also has a short plasma half-life of approximately four hours, yet provides 24-hour pain relief with a once-daily dose.

The clinical trial database for Prexige comprises approximately 40,000 patients, making it one of the largest bodies of evidence for any drug in its class. This includes the results of TARGET (Therapeutic Arthritis Research and Gastrointestinal Trial) involving more than 18,000 patients[10]. Results of this trial showed Prexige also significantly reduced the incidence of upper gastrointestinal complications by 79% in patients not taking aspirin compared to ibuprofen and naproxen[11].

Novartis supports the recommendation of health authorities that anti-inflammatory treatments should be used in appropriate patients at the lowest possible dose for the shortest possible duration.

Disclaimer The foregoing press release contains forward-looking statements such as "can," "may," or similar expressions, or by express or implied discussions regarding potential future regulatory filings or approvals or potential future sales of Prexige® (lumiracoxib). Such forward-looking statements reflect the current views of Novartis regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results with Prexige® (lumiracoxib) to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that Prexige® (lumiracoxib) will be approved for sale in the U.S. or any other additional markets, or for any additional indicatio
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:5/22/2013)... , May 22, 2013 Hemoglobin ... commercially-insured patients with Type 2 diabetes, while modest ... improve health outcomes and can lead to substantial ... at the International Society for Pharmacoeconomics and Outcomes ... The two studies, sponsored by Valeritas, makers of ...
(Date:5/22/2013)... Ohio , May 22, 2013   Life ... health screening services announced today the creation of a ... (MCM) . MCM is a population ... to MCM,s growing list of clients. These important expanded ... costly chronic conditions earlier. Effective prevention reduces cost of ...
(Date:5/22/2013)... May 22, 2013  Avanir Pharmaceuticals, Inc. (NASDAQ: ... overview of the company at the following conferences. ... Presentation date: Wednesday May 29, 2013 , Presentation time: ... Healthcare Conference , Presentation date: Wednesday June 5, 2013 ... A live webcast and 30-day archive of ...
Breaking Medicine Technology:Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 2Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 3Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 4Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 5Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 6Life Line Screening and MCM Solutions for Better Health Announce New Partnership 2Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences 2
... Diabetic patients diagnosed with peripheral neuropathy had lower ... when treated with a folate-enriched prescription medical food, ... Society for Pharmacoeconomics and Outcomes Research 12th Annual ... Inc. study, funded by Pamlab, L.L.C., which manufactures ...
... Genomma Lab Internacional, S.A.B. de C.V. (BMV: ... for the quarter ended September 30, 2009. All figures ... are stated in nominal Mexican pesos. Also, the following consolidated ... according to Mexican GAAP. , 3Q09 Highlights (vs. 3Q08) ...
Cached Medicine Technology:Medical Food Reduces Medical Costs and Use of Anticonvulsant Medication When Treating Diabetic Neuropathy, According to HealthCore Study Presented at ISPOR 2Medical Food Reduces Medical Costs and Use of Anticonvulsant Medication When Treating Diabetic Neuropathy, According to HealthCore Study Presented at ISPOR 3Genomma Lab Internacional Announces Third Quarter 2009 Results 2Genomma Lab Internacional Announces Third Quarter 2009 Results 3
(Date:5/22/2013)... is a gender gap when it comes to behavior ... does not appear to exist in children in Asia. ... of self-regulation than boys. Self-regulation is defined as children,s ... and persist on a task. It has been linked ... by Oregon State University researchers. , In three ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Successful ... by Patricia O’Laughlin Psychotherapy in the Silver Lake ... of all ages as progression to existing Parents ... all ages into parenting therapy has always been ... Patricia O’Laughlin Psychotherapy now specializes in all aspects ...
(Date:5/22/2013)... 22, 2013 Diversity Focus and Handicap ... The performance promotes awareness that physical disabilities do ... This! performance will be held Friday, June 14th at ... Tickets for Handicap This! can be purchased at ... measure the level to which their mind is handicap ...
(Date:5/22/2013)... City, UT (PRWEB) May 22, 2013 ... the Alabama Health Insurance Exchange . Zane Benefits, ... sponsored health benefits, is the leader in defined ... , According to Zane Benefits’ website, beginning in 2014 ... insurance coverage for individuals and small businesses will become ...
(Date:5/22/2013)... 22 (HealthDay News) -- Over the next two decades, ... is expected to more than double, topping more than ... The main factor driving the increase: an aging population. ... the American Stroke Association, was published May 22 in ... strain the health care system," Dr. Bruce Ovbiagele, chairman ...
Breaking Medicine News(10 mins):Health News:'Boys will be boys' in US, but not in Asia 2Health News:'Boys will be boys' in US, but not in Asia 3Health News:Patricia O’Laughlin Psychotherapy of Los Angeles Now Seeing Adults, Teens and Young Children 2Health News:Handicap This! Comes to Marion, Iowa 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 3Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 2Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 3
... Cincinnati (UC) Department of Emergency Medicine has received a ... to study the implementation of electronic health records in ... support the work of Michael Ward, MD, an assistant ... the past year focusing on simulation modeling in operations ...
... , TUESDAY, June 7 (HealthDay News) -- Children who ... in life, a new study of nearly 18,000 cancer survivors ... first diagnosed before the age of 15 over 25 years. ... 1,222 of the survivors. The most common tumors, the study ...
... (HealthDay News) -- Increasing out-of-pocket expenses forces many cancer ... doctor appointments and to cut back on food and ... looked at 216 cancer patients who sought help from ... afford expensive medications. All but one patient had insurance, ...
... of dollars spent on health care each year, the ... for life expectancy at birth. Leading causes of infant ... birth weight-outcomes that have been linked with domestic violence. ... in addressing this issue is preventing violence against mothers ...
... objects, sounds, smells and events: far too much for us ... automatically be snagged by something startling, such as a slamming ... important to us right then, such as locating our child ... also know that people are hard-wired to seek out and ...
... , TUESDAY, June 7 (HealthDay News) -- Women who ... have chubbier babies, a possible risk factor for childhood obesity, ... normal weight women gain 25 to 35 pounds during pregnancy. ... pounds, while obese women should limit weight gain to 11 ...
Cached Medicine News:Health News:Using simulation to model the implementation of electronic health records 2Health News:Childhood Cancer Survivors at Greater Risk for Tumors as Adults 2Health News:Cancer Patients Struggle as Drug Costs Soar: Study 2Health News:Health care providers need training to recognize signs of domestic violence, says nursing expert 2Health News:Your attention please: 'Rewarding' objects can't be ignored 2Health News:Your attention please: 'Rewarding' objects can't be ignored 3Health News:Too Much Weight Gain in Pregnancy Linked to Chubby Babies 2
... for laboratories looking for time and cost ... operation in terms of easy reagent cassette ... on-board stability., ,URISYS 2400 is a ... capability for medium to high volume laboratories ...
... The Small Joint Ball Electrode ... in small joint applications. With its ... tip, controlled capsuloligamentous or tendinous tissue ... When used in conjunction with the ...
Acufex arthroscopic electrodes are insulated for use in all fluids and come in boxes of 10....
... The Assistant Free ... retractors utilizing Velcro® straps. ... of the surgeon's operative ... personnel. Three retractor styles ...
Medicine Products: